• レポートコード:QYR2104Z4827 • 出版社/出版日:QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態:英文、PDF、97ページ • 納品方法:Eメール(納期:3日) • 産業分類:医療 |
Single User | ¥553,800 (USD3,900) | ▷ お問い合わせ |
Multi User/Five User | ¥830,700 (USD5,850) | ▷ お問い合わせ |
Enterprise License(同一法人内共有可) | ¥1,107,600 (USD7,800) | ▷ お問い合わせ |
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
QYResearch社発行の本調査資料では、前立腺がんバイオマーカーのグローバル市場(2016年~2027年)について調べ、市場動向、主要企業の市場シェア、種類別市場規模(尿、血、血清)、用途別市場規模(病院、診療所、がん研究機関)、主要地域別市場規模(北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等)、関連企業情報などを掲載しています。 ・市場概要 ・前立腺がんバイオマーカーの市場動向 ・企業の競争状況、市場シェア ・前立腺がんバイオマーカーの種類別市場規模(尿、血、血清) ・前立腺がんバイオマーカーの用途別市場規模(病院、診療所、がん研究機関) ・前立腺がんバイオマーカーの北米市場規模2016-2027(アメリカ、カナダ) ・前立腺がんバイオマーカーのヨーロッパ市場規模2016-2027(ドイツ、フランス、イギリス等) ・前立腺がんバイオマーカーのアジア市場規模2016-2027(日本、中国、韓国、インド、東南アジア等) ・前立腺がんバイオマーカーの中南米市場規模2016-2027(メキシコ、ブラジル) ・前立腺がんバイオマーカーの中東・アフリカ市場規模2016-2027(トルコ、サウジアラビア等) ・主要企業情報(Thermo Fisher Scientific、QIAGEN、Roche Diagnostics、Beckman Coulter、Myriad Genetics、Sanofi-Aventis、Pfizer、MDx Health) ・結論 |
Prostate cancer is the development of cancer in the prostate, a gland in the male reproductive system.
The prostate cancer biomarker market is expected to witness a fast growth owing to rising prevalence of prostate cancer.
Market Analysis and Insights: Global Prostate Cancer Biomarker Market
The global Prostate Cancer Biomarker market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Prostate Cancer Biomarker market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Prostate Cancer Biomarker market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Prostate Cancer Biomarker market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Prostate Cancer Biomarker market.
Global Prostate Cancer Biomarker Scope and Market Size
Prostate Cancer Biomarker market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Prostate Cancer Biomarker market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Urine
Blood
Serum
Segment by Application
Hospitals
Clinics
Cancer Institutes
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Thermo Fisher Scientific
QIAGEN
Roche Diagnostics
Beckman Coulter
Myriad Genetics
Sanofi-Aventis
Pfizer
MDx Health
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Prostate Cancer Biomarker Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Urine
1.2.3 Blood
1.2.4 Serum
1.3 Market by Application
1.3.1 Global Prostate Cancer Biomarker Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Cancer Institutes
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Prostate Cancer Biomarker Market Perspective (2016-2027)
2.2 Prostate Cancer Biomarker Growth Trends by Regions
2.2.1 Prostate Cancer Biomarker Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Prostate Cancer Biomarker Historic Market Share by Regions (2016-2021)
2.2.3 Prostate Cancer Biomarker Forecasted Market Size by Regions (2022-2027)
2.3 Prostate Cancer Biomarker Industry Dynamic
2.3.1 Prostate Cancer Biomarker Market Trends
2.3.2 Prostate Cancer Biomarker Market Drivers
2.3.3 Prostate Cancer Biomarker Market Challenges
2.3.4 Prostate Cancer Biomarker Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Prostate Cancer Biomarker Players by Revenue
3.1.1 Global Top Prostate Cancer Biomarker Players by Revenue (2016-2021)
3.1.2 Global Prostate Cancer Biomarker Revenue Market Share by Players (2016-2021)
3.2 Global Prostate Cancer Biomarker Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Prostate Cancer Biomarker Revenue
3.4 Global Prostate Cancer Biomarker Market Concentration Ratio
3.4.1 Global Prostate Cancer Biomarker Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Prostate Cancer Biomarker Revenue in 2020
3.5 Prostate Cancer Biomarker Key Players Head office and Area Served
3.6 Key Players Prostate Cancer Biomarker Product Solution and Service
3.7 Date of Enter into Prostate Cancer Biomarker Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Prostate Cancer Biomarker Breakdown Data by Type
4.1 Global Prostate Cancer Biomarker Historic Market Size by Type (2016-2021)
4.2 Global Prostate Cancer Biomarker Forecasted Market Size by Type (2022-2027)
5 Prostate Cancer Biomarker Breakdown Data by Application
5.1 Global Prostate Cancer Biomarker Historic Market Size by Application (2016-2021)
5.2 Global Prostate Cancer Biomarker Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Prostate Cancer Biomarker Market Size (2016-2027)
6.2 North America Prostate Cancer Biomarker Market Size by Type
6.2.1 North America Prostate Cancer Biomarker Market Size by Type (2016-2021)
6.2.2 North America Prostate Cancer Biomarker Market Size by Type (2022-2027)
6.2.3 North America Prostate Cancer Biomarker Market Size by Type (2016-2027)
6.3 North America Prostate Cancer Biomarker Market Size by Application
6.3.1 North America Prostate Cancer Biomarker Market Size by Application (2016-2021)
6.3.2 North America Prostate Cancer Biomarker Market Size by Application (2022-2027)
6.3.3 North America Prostate Cancer Biomarker Market Size by Application (2016-2027)
6.4 North America Prostate Cancer Biomarker Market Size by Country
6.4.1 North America Prostate Cancer Biomarker Market Size by Country (2016-2021)
6.4.2 North America Prostate Cancer Biomarker Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Prostate Cancer Biomarker Market Size (2016-2027)
7.2 Europe Prostate Cancer Biomarker Market Size by Type
7.2.1 Europe Prostate Cancer Biomarker Market Size by Type (2016-2021)
7.2.2 Europe Prostate Cancer Biomarker Market Size by Type (2022-2027)
7.2.3 Europe Prostate Cancer Biomarker Market Size by Type (2016-2027)
7.3 Europe Prostate Cancer Biomarker Market Size by Application
7.3.1 Europe Prostate Cancer Biomarker Market Size by Application (2016-2021)
7.3.2 Europe Prostate Cancer Biomarker Market Size by Application (2022-2027)
7.3.3 Europe Prostate Cancer Biomarker Market Size by Application (2016-2027)
7.4 Europe Prostate Cancer Biomarker Market Size by Country
7.4.1 Europe Prostate Cancer Biomarker Market Size by Country (2016-2021)
7.4.2 Europe Prostate Cancer Biomarker Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Prostate Cancer Biomarker Market Size (2016-2027)
8.2 Asia-Pacific Prostate Cancer Biomarker Market Size by Type
8.2.1 Asia-Pacific Prostate Cancer Biomarker Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Prostate Cancer Biomarker Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Prostate Cancer Biomarker Market Size by Type (2016-2027)
8.3 Asia-Pacific Prostate Cancer Biomarker Market Size by Application
8.3.1 Asia-Pacific Prostate Cancer Biomarker Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Prostate Cancer Biomarker Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Prostate Cancer Biomarker Market Size by Application (2016-2027)
8.4 Asia-Pacific Prostate Cancer Biomarker Market Size by Region
8.4.1 Asia-Pacific Prostate Cancer Biomarker Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Prostate Cancer Biomarker Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Prostate Cancer Biomarker Market Size (2016-2027)
9.2 Latin America Prostate Cancer Biomarker Market Size by Type
9.2.1 Latin America Prostate Cancer Biomarker Market Size by Type (2016-2021)
9.2.2 Latin America Prostate Cancer Biomarker Market Size by Type (2022-2027)
9.2.3 Latin America Prostate Cancer Biomarker Market Size by Type (2016-2027)
9.3 Latin America Prostate Cancer Biomarker Market Size by Application
9.3.1 Latin America Prostate Cancer Biomarker Market Size by Application (2016-2021)
9.3.2 Latin America Prostate Cancer Biomarker Market Size by Application (2022-2027)
9.3.3 Latin America Prostate Cancer Biomarker Market Size by Application (2016-2027)
9.4 Latin America Prostate Cancer Biomarker Market Size by Country
9.4.1 Latin America Prostate Cancer Biomarker Market Size by Country (2016-2021)
9.4.2 Latin America Prostate Cancer Biomarker Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Prostate Cancer Biomarker Market Size (2016-2027)
10.2 Middle East & Africa Prostate Cancer Biomarker Market Size by Type
10.2.1 Middle East & Africa Prostate Cancer Biomarker Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Prostate Cancer Biomarker Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Prostate Cancer Biomarker Market Size by Type (2016-2027)
10.3 Middle East & Africa Prostate Cancer Biomarker Market Size by Application
10.3.1 Middle East & Africa Prostate Cancer Biomarker Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Prostate Cancer Biomarker Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Prostate Cancer Biomarker Market Size by Application (2016-2027)
10.4 Middle East & Africa Prostate Cancer Biomarker Market Size by Country
10.4.1 Middle East & Africa Prostate Cancer Biomarker Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Prostate Cancer Biomarker Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Thermo Fisher Scientific
11.1.1 Thermo Fisher Scientific Company Details
11.1.2 Thermo Fisher Scientific Business Overview
11.1.3 Thermo Fisher Scientific Prostate Cancer Biomarker Introduction
11.1.4 Thermo Fisher Scientific Revenue in Prostate Cancer Biomarker Business (2016-2021)
11.1.5 Thermo Fisher Scientific Recent Development
11.2 QIAGEN
11.2.1 QIAGEN Company Details
11.2.2 QIAGEN Business Overview
11.2.3 QIAGEN Prostate Cancer Biomarker Introduction
11.2.4 QIAGEN Revenue in Prostate Cancer Biomarker Business (2016-2021)
11.2.5 QIAGEN Recent Development
11.3 Roche Diagnostics
11.3.1 Roche Diagnostics Company Details
11.3.2 Roche Diagnostics Business Overview
11.3.3 Roche Diagnostics Prostate Cancer Biomarker Introduction
11.3.4 Roche Diagnostics Revenue in Prostate Cancer Biomarker Business (2016-2021)
11.3.5 Roche Diagnostics Recent Development
11.4 Beckman Coulter
11.4.1 Beckman Coulter Company Details
11.4.2 Beckman Coulter Business Overview
11.4.3 Beckman Coulter Prostate Cancer Biomarker Introduction
11.4.4 Beckman Coulter Revenue in Prostate Cancer Biomarker Business (2016-2021)
11.4.5 Beckman Coulter Recent Development
11.5 Myriad Genetics
11.5.1 Myriad Genetics Company Details
11.5.2 Myriad Genetics Business Overview
11.5.3 Myriad Genetics Prostate Cancer Biomarker Introduction
11.5.4 Myriad Genetics Revenue in Prostate Cancer Biomarker Business (2016-2021)
11.5.5 Myriad Genetics Recent Development
11.6 Sanofi-Aventis
11.6.1 Sanofi-Aventis Company Details
11.6.2 Sanofi-Aventis Business Overview
11.6.3 Sanofi-Aventis Prostate Cancer Biomarker Introduction
11.6.4 Sanofi-Aventis Revenue in Prostate Cancer Biomarker Business (2016-2021)
11.6.5 Sanofi-Aventis Recent Development
11.7 Pfizer
11.7.1 Pfizer Company Details
11.7.2 Pfizer Business Overview
11.7.3 Pfizer Prostate Cancer Biomarker Introduction
11.7.4 Pfizer Revenue in Prostate Cancer Biomarker Business (2016-2021)
11.7.5 Pfizer Recent Development
11.8 MDx Health
11.8.1 MDx Health Company Details
11.8.2 MDx Health Business Overview
11.8.3 MDx Health Prostate Cancer Biomarker Introduction
11.8.4 MDx Health Revenue in Prostate Cancer Biomarker Business (2016-2021)
11.8.5 MDx Health Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Prostate Cancer Biomarker Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Urine
Table 3. Key Players of Blood
Table 4. Key Players of Serum
Table 5. Global Prostate Cancer Biomarker Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Prostate Cancer Biomarker Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Prostate Cancer Biomarker Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Prostate Cancer Biomarker Market Share by Regions (2016-2021)
Table 9. Global Prostate Cancer Biomarker Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Prostate Cancer Biomarker Market Share by Regions (2022-2027)
Table 11. Prostate Cancer Biomarker Market Trends
Table 12. Prostate Cancer Biomarker Market Drivers
Table 13. Prostate Cancer Biomarker Market Challenges
Table 14. Prostate Cancer Biomarker Market Restraints
Table 15. Global Prostate Cancer Biomarker Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Prostate Cancer Biomarker Market Share by Players (2016-2021)
Table 17. Global Top Prostate Cancer Biomarker Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Prostate Cancer Biomarker as of 2020)
Table 18. Ranking of Global Top Prostate Cancer Biomarker Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Prostate Cancer Biomarker Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Prostate Cancer Biomarker Product Solution and Service
Table 22. Date of Enter into Prostate Cancer Biomarker Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Prostate Cancer Biomarker Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Prostate Cancer Biomarker Revenue Market Share by Type (2016-2021)
Table 26. Global Prostate Cancer Biomarker Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Prostate Cancer Biomarker Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Prostate Cancer Biomarker Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Prostate Cancer Biomarker Revenue Market Share by Application (2016-2021)
Table 30. Global Prostate Cancer Biomarker Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Prostate Cancer Biomarker Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Prostate Cancer Biomarker Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Prostate Cancer Biomarker Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Prostate Cancer Biomarker Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Prostate Cancer Biomarker Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Prostate Cancer Biomarker Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Prostate Cancer Biomarker Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Prostate Cancer Biomarker Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Prostate Cancer Biomarker Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Prostate Cancer Biomarker Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Prostate Cancer Biomarker Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Prostate Cancer Biomarker Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Prostate Cancer Biomarker Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Prostate Cancer Biomarker Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Prostate Cancer Biomarker Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Prostate Cancer Biomarker Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Prostate Cancer Biomarker Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Prostate Cancer Biomarker Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Prostate Cancer Biomarker Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Prostate Cancer Biomarker Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Prostate Cancer Biomarker Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Prostate Cancer Biomarker Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Prostate Cancer Biomarker Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Prostate Cancer Biomarker Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Prostate Cancer Biomarker Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Prostate Cancer Biomarker Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Prostate Cancer Biomarker Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Prostate Cancer Biomarker Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Prostate Cancer Biomarker Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Prostate Cancer Biomarker Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Prostate Cancer Biomarker Market Size by Country (2022-2027) & (US$ Million)
Table 62. Thermo Fisher Scientific Company Details
Table 63. Thermo Fisher Scientific Business Overview
Table 64. Thermo Fisher Scientific Prostate Cancer Biomarker Product
Table 65. Thermo Fisher Scientific Revenue in Prostate Cancer Biomarker Business (2016-2021) & (US$ Million)
Table 66. Thermo Fisher Scientific Recent Development
Table 67. QIAGEN Company Details
Table 68. QIAGEN Business Overview
Table 69. QIAGEN Prostate Cancer Biomarker Product
Table 70. QIAGEN Revenue in Prostate Cancer Biomarker Business (2016-2021) & (US$ Million)
Table 71. QIAGEN Recent Development
Table 72. Roche Diagnostics Company Details
Table 73. Roche Diagnostics Business Overview
Table 74. Roche Diagnostics Prostate Cancer Biomarker Product
Table 75. Roche Diagnostics Revenue in Prostate Cancer Biomarker Business (2016-2021) & (US$ Million)
Table 76. Roche Diagnostics Recent Development
Table 77. Beckman Coulter Company Details
Table 78. Beckman Coulter Business Overview
Table 79. Beckman Coulter Prostate Cancer Biomarker Product
Table 80. Beckman Coulter Revenue in Prostate Cancer Biomarker Business (2016-2021) & (US$ Million)
Table 81. Beckman Coulter Recent Development
Table 82. Myriad Genetics Company Details
Table 83. Myriad Genetics Business Overview
Table 84. Myriad Genetics Prostate Cancer Biomarker Product
Table 85. Myriad Genetics Revenue in Prostate Cancer Biomarker Business (2016-2021) & (US$ Million)
Table 86. Myriad Genetics Recent Development
Table 87. Sanofi-Aventis Company Details
Table 88. Sanofi-Aventis Business Overview
Table 89. Sanofi-Aventis Prostate Cancer Biomarker Product
Table 90. Sanofi-Aventis Revenue in Prostate Cancer Biomarker Business (2016-2021) & (US$ Million)
Table 91. Sanofi-Aventis Recent Development
Table 92. Pfizer Company Details
Table 93. Pfizer Business Overview
Table 94. Pfizer Prostate Cancer Biomarker Product
Table 95. Pfizer Revenue in Prostate Cancer Biomarker Business (2016-2021) & (US$ Million)
Table 96. Pfizer Recent Development
Table 97. MDx Health Company Details
Table 98. MDx Health Business Overview
Table 99. MDx Health Revenue in Prostate Cancer Biomarker Business (2016-2021) & (US$ Million)
Table 100. MDx Health Recent Development
Table 101. Research Programs/Design for This Report
Table 102. Key Data Information from Secondary Sources
Table 103. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Prostate Cancer Biomarker Market Share by Type: 2020 VS 2027
Figure 2. Urine Features
Figure 3. Blood Features
Figure 4. Serum Features
Figure 5. Global Prostate Cancer Biomarker Market Share by Application: 2020 VS 2027
Figure 6. Hospitals Case Studies
Figure 7. Clinics Case Studies
Figure 8. Cancer Institutes Case Studies
Figure 9. Prostate Cancer Biomarker Report Years Considered
Figure 10. Global Prostate Cancer Biomarker Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Prostate Cancer Biomarker Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Prostate Cancer Biomarker Market Share by Regions: 2020 VS 2027
Figure 13. Global Prostate Cancer Biomarker Market Share by Regions (2022-2027)
Figure 14. Global Prostate Cancer Biomarker Market Share by Players in 2020
Figure 15. Global Top Prostate Cancer Biomarker Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Prostate Cancer Biomarker as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Prostate Cancer Biomarker Revenue in 2020
Figure 17. Global Prostate Cancer Biomarker Revenue Market Share by Type (2016-2021)
Figure 18. Global Prostate Cancer Biomarker Revenue Market Share by Type (2022-2027)
Figure 19. North America Prostate Cancer Biomarker Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Prostate Cancer Biomarker Market Share by Type (2016-2027)
Figure 21. North America Prostate Cancer Biomarker Market Share by Application (2016-2027)
Figure 22. North America Prostate Cancer Biomarker Market Share by Country (2016-2027)
Figure 23. United States Prostate Cancer Biomarker Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Prostate Cancer Biomarker Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Prostate Cancer Biomarker Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Prostate Cancer Biomarker Market Share by Type (2016-2027)
Figure 27. Europe Prostate Cancer Biomarker Market Share by Application (2016-2027)
Figure 28. Europe Prostate Cancer Biomarker Market Share by Country (2016-2027)
Figure 29. Germany Prostate Cancer Biomarker Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Prostate Cancer Biomarker Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Prostate Cancer Biomarker Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Prostate Cancer Biomarker Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Prostate Cancer Biomarker Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Prostate Cancer Biomarker Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Prostate Cancer Biomarker Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Prostate Cancer Biomarker Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Prostate Cancer Biomarker Market Share by Application (2016-2027)
Figure 38. Asia-Pacific Prostate Cancer Biomarker Market Share by Region (2016-2027)
Figure 39. China Prostate Cancer Biomarker Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Prostate Cancer Biomarker Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Prostate Cancer Biomarker Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Prostate Cancer Biomarker Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Prostate Cancer Biomarker Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Prostate Cancer Biomarker Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Prostate Cancer Biomarker Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Prostate Cancer Biomarker Market Share by Type (2016-2027)
Figure 47. Latin America Prostate Cancer Biomarker Market Share by Application (2016-2027)
Figure 48. Latin America Prostate Cancer Biomarker Market Share by Country (2016-2027)
Figure 49. Mexico Prostate Cancer Biomarker Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Prostate Cancer Biomarker Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Prostate Cancer Biomarker Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Prostate Cancer Biomarker Market Share by Type (2016-2027)
Figure 53. Middle East & Africa Prostate Cancer Biomarker Market Share by Application (2016-2027)
Figure 54. Middle East & Africa Prostate Cancer Biomarker Market Share by Country (2016-2027)
Figure 55. Turkey Prostate Cancer Biomarker Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Prostate Cancer Biomarker Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Prostate Cancer Biomarker Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Thermo Fisher Scientific Revenue Growth Rate in Prostate Cancer Biomarker Business (2016-2021)
Figure 59. QIAGEN Revenue Growth Rate in Prostate Cancer Biomarker Business (2016-2021)
Figure 60. Roche Diagnostics Revenue Growth Rate in Prostate Cancer Biomarker Business (2016-2021)
Figure 61. Beckman Coulter Revenue Growth Rate in Prostate Cancer Biomarker Business (2016-2021)
Figure 62. Myriad Genetics Revenue Growth Rate in Prostate Cancer Biomarker Business (2016-2021)
Figure 63. Sanofi-Aventis Revenue Growth Rate in Prostate Cancer Biomarker Business (2016-2021)
Figure 64. Pfizer Revenue Growth Rate in Prostate Cancer Biomarker Business (2016-2021)
Figure 65. MDx Health Revenue Growth Rate in Prostate Cancer Biomarker Business (2016-2021)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed